1. Home
  2. CCII vs AMRN Comparison

CCII vs AMRN Comparison

Compare CCII & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCII
  • AMRN
  • Stock Information
  • Founded
  • CCII 2024
  • AMRN 1989
  • Country
  • CCII United States
  • AMRN Ireland
  • Employees
  • CCII N/A
  • AMRN N/A
  • Industry
  • CCII
  • AMRN Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCII
  • AMRN Health Care
  • Exchange
  • CCII Nasdaq
  • AMRN Nasdaq
  • Market Cap
  • CCII 350.7M
  • AMRN 302.0M
  • IPO Year
  • CCII 2025
  • AMRN 1993
  • Fundamental
  • Price
  • CCII $10.17
  • AMRN $19.33
  • Analyst Decision
  • CCII
  • AMRN Strong Sell
  • Analyst Count
  • CCII 0
  • AMRN 1
  • Target Price
  • CCII N/A
  • AMRN $12.00
  • AVG Volume (30 Days)
  • CCII 134.2K
  • AMRN 81.9K
  • Earning Date
  • CCII 01-01-0001
  • AMRN 10-29-2025
  • Dividend Yield
  • CCII N/A
  • AMRN N/A
  • EPS Growth
  • CCII N/A
  • AMRN N/A
  • EPS
  • CCII N/A
  • AMRN N/A
  • Revenue
  • CCII N/A
  • AMRN $219,361,000.00
  • Revenue This Year
  • CCII N/A
  • AMRN N/A
  • Revenue Next Year
  • CCII N/A
  • AMRN N/A
  • P/E Ratio
  • CCII N/A
  • AMRN N/A
  • Revenue Growth
  • CCII N/A
  • AMRN N/A
  • 52 Week Low
  • CCII $10.07
  • AMRN $7.08
  • 52 Week High
  • CCII $10.20
  • AMRN $20.42
  • Technical
  • Relative Strength Index (RSI)
  • CCII N/A
  • AMRN 86.31
  • Support Level
  • CCII N/A
  • AMRN $15.24
  • Resistance Level
  • CCII N/A
  • AMRN $15.74
  • Average True Range (ATR)
  • CCII 0.00
  • AMRN 0.73
  • MACD
  • CCII 0.00
  • AMRN 0.41
  • Stochastic Oscillator
  • CCII 0.00
  • AMRN 81.47

About CCII Cohen Circle Acquisition Corp. II Class A Ordinary Shares

Cohen Circle Acquisition Corp II is a blank check company.

About AMRN Amarin Corporation plc

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Share on Social Networks: